Uchenna O. Umeh

Uchenna O. Umeh

Auto-generated profile, based on publicly available information

Uchenna O. Umeh

Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery, New York, New York

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in JBJS Reviews
Verified
Journal Article
Closed access
MBMichael A. Boin
Michael A. Boin
DMDevan Mehta
Devan Mehta
JDJohn Dankert
John Dankert
UUUchenna O. Umeh
Uchenna O. Umeh
JZJoseph Zuckerman
Joseph Zuckerman
MVMandeep Virk
Mandeep Virk
» For shoulder arthroplasty, regional anesthesia is safer when compared with general anesthesia. There is insufficient evidence to demonstrate the superiority of regional anesthesia with respect to pulmonary complications and hospital length of stay. » Infiltration of the shoulder with local anesthetics offers no additional benefits compared with single-shot or continuous brachial plexus blocks for shoulder arthroplasty. » There is high-quality evidence (Level I) demonstrating lower pain scores and lower perioperative opioid requirements after a continuous peripheral nerve block compared with a single-shot nerve block. However, catheter dislodgment and logistical issues with catheter insertion are impediments to the widespread usage of a continuous nerve block with an indwelling catheter. » Liposomal bupivacaine is comparable with non-liposomal local anesthetic agents with respect to pain relief, the opioid-sparing effect, and adverse effects in the first 48 hours after total shoulder arthroplasty. » Perioperative dexamethasone administration improves postoperative pain control, decreases perioperative opioid requirements, and reduces postoperative nausea.

19 March 2024 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
UUUchenna O. Umeh
Uchenna O. Umeh

24 June 2022 in Health Sciences Review
Verified
Journal Article
Open access
NFNina D. Fisher
Nina D. Fisher
ABAndrew S. Bi
Andrew S. Bi
UUUchenna O. Umeh
Uchenna O. Umeh
AVAnsara M. Vaz
Ansara M. Vaz
KEKenneth A. Egol
Kenneth A. Egol

7 June 2022 in Trends in Anaesthesia and Critical Care
Verified
Journal Article
Closed access
UUUchenna O. Umeh
Uchenna O. Umeh
FRFiona Roediger
Fiona Roediger
GCGermaine Cuff
Germaine Cuff
YRYevgeniy Romanenko
Yevgeniy Romanenko
AVAnsara Vaz
Ansara Vaz
AHArthur Hertling
Arthur Hertling

12 June 2023 in Arthroplasty Today
Verified
Journal Article
Open access
JAJerry Arraut
Jerry Arraut
JTJeremiah Thomas
Jeremiah Thomas
COChristian Oakley
Christian Oakley
UUUchenna O. Umeh
Uchenna O. Umeh
DFDavid L. Furgiuele
David L. Furgiuele
RSRan Schwarzkopf
Ran Schwarzkopf
Patients undergoing revision total knee arthroplasty (rTKA) have historically received high doses of opioids during the perioperative period. As awareness of opioid use has heightened, opioid administration has continuously decreased. This study aimed to evaluate if peripheral nerve catheter (PNC) use in rTKA reduces opiate consumption while maintaining similar pain control and postoperative function levels. A retrospective review of 354 patients who underwent rTKA between July 2019 and January 2022 was conducted. Fifty total patients who received an adductor canal PNC were propensity-matched 1:1 to a control group of 50 patients that did not receive a PNC. To assess the primary outcome of opiate consumption, nursing documented opiate administration events were converted into morphine milligram equivalents per 24-hour interval. Postoperative pain and functional status were assessed using the verbal rating scale for pain and the Activity Measure for Post-Acute Care scores, respectively. Compared to the control group, the PNC group demonstrated significantly lower overall inpatient opiate consumption (98.68 ± 117.03 vs 176.69 ± 203.47 morphine milligram equivalents; 44.15% decrease, P = .021) and lower verbal rating scale pain scores at 60 to 72 hours postoperatively (4.85 ± 1.24 vs 5.83 ± 1.35; 16.81% decrease, P = .038). There was no significant difference in Activity Measure for Post-Acute Care scores postoperatively (raw score: 19.41 ± 3.61 vs 19.46 ± 3.18; 0.26% decrease, P = .952). Finally, the PNC cohort was significantly less likely to be readmitted within 90 days after surgery (0.0% vs 12.0%; P = .012). In rTKA patients, PNC can significantly reduce inpatient opioid consumption while maintaining a comparable functional recovery and superior pain control. Retrospective Cohort Study.

1 July 2021 in JBJS Reviews
Verified
Journal Article
Closed access
CPCody R. Perskin
Cody R. Perskin
CLConnor P. Littlefield
Connor P. Littlefield
CWCharles Wang
Charles Wang
UUUchenna Umeh
Uchenna Umeh
KEKenneth A. Egol
Kenneth A. Egol
» Tranexamic acid (TXA) is a drug used to control hemorrhage by preventing the breakdown of fibrin. » TXA is a cost-effective treatment for trauma patients across a variety of economic settings. » Concerns of TXA causing thromboembolic events (TEEs) in orthopaedic trauma patients are not supported by evidence. » TXA has been shown to reduce blood loss in hip fracture surgery.